NANOSHELL DRUG DELIVERY SYSTEM FOR ACUTE MYELOID LEUKAEMIA TREATMENT
| Reference number | |
| Coordinator | NANEXA AB |
| Funding from Vinnova | SEK 500 000 |
| Project duration | December 2018 - July 2019 |
| Status | Completed |
Important results from the project
The goal of the project was to develop a business plan for Nanexa´s continued growth and profitability.
Expected long term effects
The business plan that has been developed will guide the strategic clinical studies and market development activities to be performed by Nanexa´s team.
Approach and implementation
The feasibility assessment included preparation of clinical studies, identification of strategic partners and market analysis.